Wargasetia, Teresa Liliana and Widodo, Nashi (2017) Marine Compounds Screening for Mortalin-p53 binding Inhibitor with Potential as Anti-Cancer. In: 10th European Conference on Marine Natural Products, September 3-7, 2017, Crete.
|
Text
Update_ECMNP 2017 + poster.pdf - Published Version Download (3288Kb) | Preview |
Abstract
Cancer is the second leading cause of death worldwide. High toxicity and side-effects of some cancer chemotherapy drugs increase the demand for new anti-cancer drugs from natural products. In recent years, attention has been devoted to searching for anti-cancer agents from marine natural products. Mortalin/mtHsp70, a stress response protein, has been reported to contribute to the process of carcinogenesis by several ways including inhibition of the transcriptional activation of p53. In this study, we used computational molecular docking as a tool to find compounds that have potential as anti-cancer by inhibiting the binding between mortalin and p53. Marine compounds data was taken from the nuBBE database. To know the anti-cancer potential of the compounds from the database, docking mortalin to the p53 binding domain of the compounds were performed using the Vinaautodock algorithm with pyrx software. The potential inhibition of the binding of mortalin with p53 by the active compounds were analyzed by affinity binding between mortalin and the p53 binding domain of active compound ligands, also by a similarity between the position of mortalin-active compound ligand bindings with mortalin-withanone binding as a positive control. Proteins were visualized with discorystudio software.
| Item Type: | Conference or Workshop Item (Poster) |
|---|---|
| Subjects: | R Medicine > R Medicine (General) |
| Depositing User: | Perpustakaan Maranatha |
| Date Deposited: | 22 Oct 2018 02:20 |
| Last Modified: | 04 Feb 2023 00:11 |
| URI: | http://repository.maranatha.edu/id/eprint/24982 |
Actions (login required)
 |
View Item |
